ArticlePharmacoEconomics - open2026

The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and Scotland.

Xiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.